HALOHalozyme Therapeutics, Inc.Aug 6, 2026Q2 2026
Read transcript →Halozyme Therapeutics, Inc. (HALO) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$107.35
+0.32%
Mkt Cap $13.07B
HALOHalozyme Therapeutics, Inc.Aug 6, 2026HALOHalozyme Therapeutics, Inc.May 11, 2026Q1 2026
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 17, 2026Q4 2025
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 3, 2025Q3 2025
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 6, 2025Q2 2025
Read transcript →HALOHalozyme Therapeutics, Inc.May 6, 2025Q1 2025
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 18, 2025Q4 2024
Read transcript →HALOHalozyme Therapeutics, Inc.Oct 31, 2024Q3 2024
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 6, 2024Q2 2024
Read transcript →HALOHalozyme Therapeutics, Inc.May 7, 2024Q1 2024
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 20, 2024Q4 2023
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 6, 2023Q3 2023
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 8, 2023Q2 2023
Read transcript →HALOHalozyme Therapeutics, Inc.May 9, 2023Q1 2023
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 21, 2023Q4 2022
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 8, 2022Q3 2022
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 9, 2022Q2 2022
Read transcript →HALOHalozyme Therapeutics, Inc.May 10, 2022Q1 2022
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 22, 2022Q4 2021
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 2, 2021Q3 2021
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 5, 2021Q2 2021
Read transcript →HALOHalozyme Therapeutics, Inc.May 6, 2021Q1 2021
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 23, 2021Q4 2020
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 2, 2020Q3 2020
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 6, 2020Q2 2020
Read transcript →HALOHalozyme Therapeutics, Inc.May 5, 2020Q1 2020
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 25, 2020Q4 2019
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 5, 2019Q3 2019
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 6, 2019Q2 2019
Read transcript →HALOHalozyme Therapeutics, Inc.May 2, 2019Q1 2019
Read transcript →HALOHalozyme Therapeutics, Inc.Mar 1, 2019Q4 2018
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 6, 2018Q3 2018
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 7, 2018Q2 2018
Read transcript →HALOHalozyme Therapeutics, Inc.May 8, 2018Q1 2018
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 21, 2018Q4 2017
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 7, 2017Q3 2017
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 8, 2017Q2 2017
Read transcript →HALOHalozyme Therapeutics, Inc.May 9, 2017Q1 2017
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 28, 2017Q4 2016
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 9, 2016Q3 2016
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 9, 2016Q2 2016
Read transcript →HALOHalozyme Therapeutics, Inc.May 9, 2016Q1 2016
Read transcript →HALOHalozyme Therapeutics, Inc.Feb 29, 2016Q4 2015
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 8, 2015Q3 2015
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 10, 2015Q2 2015
Read transcript →HALOHalozyme Therapeutics, Inc.May 11, 2015Q1 2015
Read transcript →HALOHalozyme Therapeutics, Inc.Mar 2, 2015Q4 2014
Read transcript →HALOHalozyme Therapeutics, Inc.Nov 9, 2014Q3 2014
Read transcript →HALOHalozyme Therapeutics, Inc.Aug 8, 2014Q2 2014
Read transcript →HALOHalozyme Therapeutics, Inc.May 9, 2014Q1 2014
Read transcript →